Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis

Acute tubular interstitial nephritis (ATIN) is the most frequently reported pathology in patients with checkpoint inhibitor (CPI) induced acute kidney injury (AKI). Glucocorticoid (GC) therapy and discontinuation of CPI are the mainstay of treatment to prevent permanent renal dysfunction and dialysi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Lin, Jamie S., Mamlouk, Omar, Selamet, Umut, Tchakarov, Amanda, Glass, William F., Sheth, Rahul A., Layman, Rachel M., Dadu, Ramona, Abdelwahab, Noha, Abdelrahim, Maen, Diab, Adi, Yee, Cassian, Abudayyeh, Ala
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2021
Konular:
Brief Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872057/
https://ncbi.nlm.nih.gov/pubmed/33643693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1877415
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller